(Monday, January 28, 2019)
As we begin the new year, and on behalf of everyone at NINDS, I would like to thank our investigators, research subjects, and our partners representing those suffering from neurological disorders for helping us make 2018 a success.
(Wednesday, December 19, 2018)
In June 2018, NIH rolled out the Research Plan for the
(Saturday, December 1, 2018)
As the US population ages, the burden of illness due to dementia continues to grow at an alarming rate. This year the US taxpayer, through their representatives in the Congress, have appropriated an additional $425 mi
(Friday, November 2, 2018)
For so many reasons, I always look forward to the annual meeting of the Society for Neuroscience (SfN), taking place in San Diego this year from November 3-7, 2018.
(Wednesday, October 24, 2018)
Last week, the NIH Blueprint for Neuroscience Research, a group of 14 NIH Institutes, Centers and Offices (ICOs) that support research on the nervous system, released a Request for Information on the Proposed Fundin
(Friday, October 12, 2018)
In our last two updates to highlight NINDS contributions to therapies for neurological disorders, we focused on a recombinant clot-busting protein for acute stroke, enzyme replacement therapies for l
(Friday, August 10, 2018)
Researchers funded by the NIH BRAIN Initiative continue to break new ground in scientific discovery and technology development.
(Thursday, June 21, 2018)
At the end of January, we launched a new feature on our website that shows how NINDS and the research we support contribute to the discovery and development of treatments for neurologi
(Tuesday, June 12, 2018)
In last month’s NINDS Director’s message I introduced the planning stages of the NIH HEAL
(Wednesday, May 30, 2018)
NINDS Director Walter J. Koroshetz and NCI Director Norman E. Sharpless
